nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—FMO1—endometrium—polycystic ovary syndrome	0.0166	0.105	CbGeAlD
Cevimeline—CYP3A4—urine—polycystic ovary syndrome	0.0158	0.101	CbGeAlD
Cevimeline—CYP2D6—urine—polycystic ovary syndrome	0.0156	0.099	CbGeAlD
Cevimeline—FMO1—pituitary gland—polycystic ovary syndrome	0.015	0.0954	CbGeAlD
Cevimeline—FMO1—adipose tissue—polycystic ovary syndrome	0.0149	0.095	CbGeAlD
Cevimeline—FMO1—adrenal gland—polycystic ovary syndrome	0.0134	0.0852	CbGeAlD
Cevimeline—FMO1—female gonad—polycystic ovary syndrome	0.0125	0.0795	CbGeAlD
Cevimeline—FMO1—vagina—polycystic ovary syndrome	0.0124	0.079	CbGeAlD
Cevimeline—Toothache—Metformin—polycystic ovary syndrome	0.0119	0.0478	CcSEcCtD
Cevimeline—FMO1—endocrine gland—polycystic ovary syndrome	0.0116	0.0739	CbGeAlD
Cevimeline—Nail disorder—Metformin—polycystic ovary syndrome	0.0111	0.0449	CcSEcCtD
Cevimeline—Fungal infection—Metformin—polycystic ovary syndrome	0.00934	0.0377	CcSEcCtD
Cevimeline—Rigors—Metformin—polycystic ovary syndrome	0.00883	0.0356	CcSEcCtD
Cevimeline—Blood disorder—Metformin—polycystic ovary syndrome	0.00863	0.0348	CcSEcCtD
Cevimeline—Neuropathy—Metformin—polycystic ovary syndrome	0.00677	0.0273	CcSEcCtD
Cevimeline—CHRM3—adipose tissue—polycystic ovary syndrome	0.00614	0.039	CbGeAlD
Cevimeline—Ear pain—Metformin—polycystic ovary syndrome	0.00614	0.0248	CcSEcCtD
Cevimeline—Injury—Metformin—polycystic ovary syndrome	0.00569	0.023	CcSEcCtD
Cevimeline—Renal impairment—Metformin—polycystic ovary syndrome	0.0055	0.0222	CcSEcCtD
Cevimeline—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00536	0.0216	CcSEcCtD
Cevimeline—CHRM1—endocrine gland—polycystic ovary syndrome	0.00534	0.0339	CbGeAlD
Cevimeline—Pain in extremity—Metformin—polycystic ovary syndrome	0.00523	0.0211	CcSEcCtD
Cevimeline—Migraine—Metformin—polycystic ovary syndrome	0.00515	0.0208	CcSEcCtD
Cevimeline—CHRM3—female gonad—polycystic ovary syndrome	0.00514	0.0327	CbGeAlD
Cevimeline—Dehydration—Metformin—polycystic ovary syndrome	0.00487	0.0196	CcSEcCtD
Cevimeline—CHRM3—endocrine gland—polycystic ovary syndrome	0.00478	0.0304	CbGeAlD
Cevimeline—Abdominal distension—Metformin—polycystic ovary syndrome	0.00455	0.0184	CcSEcCtD
Cevimeline—Sweating increased—Metformin—polycystic ovary syndrome	0.00441	0.0178	CcSEcCtD
Cevimeline—Angina pectoris—Metformin—polycystic ovary syndrome	0.00441	0.0178	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.0042	0.017	CcSEcCtD
Cevimeline—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.00395	0.016	CcSEcCtD
Cevimeline—Rhinitis—Metformin—polycystic ovary syndrome	0.00363	0.0146	CcSEcCtD
Cevimeline—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.0036	0.0145	CcSEcCtD
Cevimeline—Oedema peripheral—Metformin—polycystic ovary syndrome	0.00357	0.0144	CcSEcCtD
Cevimeline—Eye disorder—Metformin—polycystic ovary syndrome	0.00338	0.0137	CcSEcCtD
Cevimeline—Flushing—Metformin—polycystic ovary syndrome	0.00336	0.0136	CcSEcCtD
Cevimeline—Cardiac disorder—Metformin—polycystic ovary syndrome	0.00336	0.0136	CcSEcCtD
Cevimeline—Angiopathy—Metformin—polycystic ovary syndrome	0.00329	0.0133	CcSEcCtD
Cevimeline—Chills—Metformin—polycystic ovary syndrome	0.00325	0.0131	CcSEcCtD
Cevimeline—Malnutrition—Metformin—polycystic ovary syndrome	0.00315	0.0127	CcSEcCtD
Cevimeline—Flatulence—Metformin—polycystic ovary syndrome	0.00311	0.0125	CcSEcCtD
Cevimeline—Dysgeusia—Metformin—polycystic ovary syndrome	0.00309	0.0125	CcSEcCtD
Cevimeline—Muscle spasms—Metformin—polycystic ovary syndrome	0.00303	0.0122	CcSEcCtD
Cevimeline—Tremor—Metformin—polycystic ovary syndrome	0.00295	0.0119	CcSEcCtD
Cevimeline—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.00292	0.0118	CcSEcCtD
Cevimeline—Malaise—Metformin—polycystic ovary syndrome	0.00284	0.0115	CcSEcCtD
Cevimeline—Syncope—Metformin—polycystic ovary syndrome	0.00283	0.0114	CcSEcCtD
Cevimeline—Palpitations—Metformin—polycystic ovary syndrome	0.00279	0.0112	CcSEcCtD
Cevimeline—CYP2D6—female gonad—polycystic ovary syndrome	0.00278	0.0177	CbGeAlD
Cevimeline—Loss of consciousness—Metformin—polycystic ovary syndrome	0.00277	0.0112	CcSEcCtD
Cevimeline—Hypertension—Metformin—polycystic ovary syndrome	0.00272	0.011	CcSEcCtD
Cevimeline—Chest pain—Metformin—polycystic ovary syndrome	0.00268	0.0108	CcSEcCtD
Cevimeline—Myalgia—Metformin—polycystic ovary syndrome	0.00268	0.0108	CcSEcCtD
Cevimeline—Discomfort—Metformin—polycystic ovary syndrome	0.00265	0.0107	CcSEcCtD
Cevimeline—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00262	0.0167	CbGeAlD
Cevimeline—CYP2D6—endocrine gland—polycystic ovary syndrome	0.00258	0.0164	CbGeAlD
Cevimeline—Oedema—Metformin—polycystic ovary syndrome	0.00257	0.0104	CcSEcCtD
Cevimeline—Infection—Metformin—polycystic ovary syndrome	0.00256	0.0103	CcSEcCtD
Cevimeline—Shock—Metformin—polycystic ovary syndrome	0.00253	0.0102	CcSEcCtD
Cevimeline—Nervous system disorder—Metformin—polycystic ovary syndrome	0.00252	0.0102	CcSEcCtD
Cevimeline—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.00252	0.0102	CcSEcCtD
Cevimeline—Skin disorder—Metformin—polycystic ovary syndrome	0.0025	0.0101	CcSEcCtD
Cevimeline—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.00249	0.01	CcSEcCtD
Cevimeline—Anorexia—Metformin—polycystic ovary syndrome	0.00245	0.00989	CcSEcCtD
Cevimeline—Hypotension—Metformin—polycystic ovary syndrome	0.0024	0.0097	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00234	0.00946	CcSEcCtD
Cevimeline—Paraesthesia—Metformin—polycystic ovary syndrome	0.00231	0.00932	CcSEcCtD
Cevimeline—Dyspnoea—Metformin—polycystic ovary syndrome	0.00229	0.00925	CcSEcCtD
Cevimeline—Somnolence—Metformin—polycystic ovary syndrome	0.00229	0.00923	CcSEcCtD
Cevimeline—Dyspepsia—Metformin—polycystic ovary syndrome	0.00226	0.00914	CcSEcCtD
Cevimeline—Decreased appetite—Metformin—polycystic ovary syndrome	0.00224	0.00902	CcSEcCtD
Cevimeline—Fatigue—Metformin—polycystic ovary syndrome	0.00222	0.00895	CcSEcCtD
Cevimeline—Constipation—Metformin—polycystic ovary syndrome	0.0022	0.00888	CcSEcCtD
Cevimeline—Feeling abnormal—Metformin—polycystic ovary syndrome	0.00212	0.00855	CcSEcCtD
Cevimeline—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.0021	0.00849	CcSEcCtD
Cevimeline—Urticaria—Metformin—polycystic ovary syndrome	0.00204	0.00825	CcSEcCtD
Cevimeline—Abdominal pain—Metformin—polycystic ovary syndrome	0.00203	0.00821	CcSEcCtD
Cevimeline—Asthenia—Metformin—polycystic ovary syndrome	0.00185	0.00745	CcSEcCtD
Cevimeline—Pruritus—Metformin—polycystic ovary syndrome	0.00182	0.00734	CcSEcCtD
Cevimeline—Diarrhoea—Metformin—polycystic ovary syndrome	0.00176	0.0071	CcSEcCtD
Cevimeline—Dizziness—Metformin—polycystic ovary syndrome	0.0017	0.00686	CcSEcCtD
Cevimeline—Vomiting—Metformin—polycystic ovary syndrome	0.00164	0.0066	CcSEcCtD
Cevimeline—Rash—Metformin—polycystic ovary syndrome	0.00162	0.00655	CcSEcCtD
Cevimeline—Dermatitis—Metformin—polycystic ovary syndrome	0.00162	0.00654	CcSEcCtD
Cevimeline—Headache—Metformin—polycystic ovary syndrome	0.00161	0.0065	CcSEcCtD
Cevimeline—Nausea—Metformin—polycystic ovary syndrome	0.00153	0.00617	CcSEcCtD
Cevimeline—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000393	0.00066	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—SERPINE1—polycystic ovary syndrome	0.000392	0.000659	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000389	0.000653	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000384	0.000646	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NPB—polycystic ovary syndrome	0.000383	0.000645	CbGpPWpGaD
Cevimeline—CYP2D6—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000383	0.000644	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—ADRB3—polycystic ovary syndrome	0.000383	0.000644	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NPB—polycystic ovary syndrome	0.000382	0.000643	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.00038	0.000639	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—LHB—polycystic ovary syndrome	0.000379	0.000637	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.000371	0.000624	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—GNRH1—polycystic ovary syndrome	0.00037	0.000622	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000367	0.000617	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—ADRB2—polycystic ovary syndrome	0.000366	0.000616	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000363	0.00061	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—ADRA1A—polycystic ovary syndrome	0.000362	0.000608	CbGpPWpGaD
Cevimeline—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000357	0.0006	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000356	0.000598	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—SCT—polycystic ovary syndrome	0.000355	0.000596	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000349	0.000587	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—ADRB3—polycystic ovary syndrome	0.000348	0.000585	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000347	0.000583	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PNPLA2—polycystic ovary syndrome	0.000346	0.000582	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PLEKHG5—polycystic ovary syndrome	0.000346	0.000581	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000345	0.00058	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—LHB—polycystic ovary syndrome	0.000344	0.000578	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NMNAT3—polycystic ovary syndrome	0.000342	0.000575	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.000341	0.000573	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.00034	0.000571	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—GNAS—polycystic ovary syndrome	0.00034	0.000571	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—MTNR1B—polycystic ovary syndrome	0.000338	0.000569	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—PPARG—polycystic ovary syndrome	0.000338	0.000568	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000337	0.000567	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—GNRH1—polycystic ovary syndrome	0.000336	0.000565	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—POMC—polycystic ovary syndrome	0.000333	0.00056	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—INS—polycystic ovary syndrome	0.000331	0.000557	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—SRD5A1—polycystic ovary syndrome	0.000328	0.000552	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000323	0.000543	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—SCT—polycystic ovary syndrome	0.000322	0.000542	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.00032	0.000538	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.00032	0.000538	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PTGER3—polycystic ovary syndrome	0.000319	0.000536	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LHCGR—polycystic ovary syndrome	0.000319	0.000536	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000315	0.00053	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—STAR—polycystic ovary syndrome	0.000313	0.000527	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—LPCAT2—polycystic ovary syndrome	0.000313	0.000526	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SUOX—polycystic ovary syndrome	0.000313	0.000526	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000311	0.000523	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000308	0.000518	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—MTNR1B—polycystic ovary syndrome	0.000307	0.000517	CbGpPWpGaD
Cevimeline—CHRM1—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.000301	0.000506	CbGpPWpGaD
Cevimeline—CHRM3—Class A/1 (Rhodopsin-like receptors)—POMC—polycystic ovary syndrome	0.0003	0.000505	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000299	0.000503	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PTAFR—polycystic ovary syndrome	0.000298	0.000502	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ISYNA1—polycystic ovary syndrome	0.000291	0.000489	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.000291	0.000488	CbGpPWpGaD
Cevimeline—CYP2D6—Biological oxidations—POMC—polycystic ovary syndrome	0.00029	0.000487	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADRA1D—polycystic ovary syndrome	0.00029	0.000487	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000283	0.000475	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADRA1B—polycystic ovary syndrome	0.000282	0.000474	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HMMR—polycystic ovary syndrome	0.000279	0.000469	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000275	0.000463	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—INHBB—polycystic ovary syndrome	0.000275	0.000462	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HSD3B1—polycystic ovary syndrome	0.000266	0.000448	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000257	0.000432	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PDE3B—polycystic ovary syndrome	0.000256	0.000431	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000254	0.000427	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.000251	0.000422	CbGpPWpGaD
Cevimeline—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000251	0.000421	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—GHRL—polycystic ovary syndrome	0.00025	0.00042	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	0.000247	0.000416	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	0.000247	0.000416	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—LHB—polycystic ovary syndrome	0.000243	0.000408	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—HSD3B2—polycystic ovary syndrome	0.000237	0.000399	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000234	0.000394	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FSHR—polycystic ovary syndrome	0.000233	0.000393	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AKR1C1—polycystic ovary syndrome	0.00023	0.000387	CbGpPWpGaD
Cevimeline—CHRM1—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000229	0.000386	CbGpPWpGaD
Cevimeline—CHRM3—GPCR ligand binding—POMC—polycystic ovary syndrome	0.000229	0.000384	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000228	0.000383	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—GHRL—polycystic ovary syndrome	0.000227	0.000382	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000224	0.000376	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00022	0.00037	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RACGAP1—polycystic ovary syndrome	0.00022	0.000369	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000214	0.00036	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.000214	0.000359	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—SULT2A1—polycystic ovary syndrome	0.000212	0.000356	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FST—polycystic ovary syndrome	0.000209	0.000351	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FST—polycystic ovary syndrome	0.000208	0.00035	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000208	0.000349	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	0.000207	0.000348	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000207	0.000348	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000206	0.000347	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000206	0.000346	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—RRM2—polycystic ovary syndrome	0.000205	0.000345	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000204	0.000344	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000204	0.000344	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LHB—polycystic ovary syndrome	0.000204	0.000343	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LHB—polycystic ovary syndrome	0.000203	0.000341	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000199	0.000335	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000199	0.000334	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—YAP1—polycystic ovary syndrome	0.000198	0.000332	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	0.000196	0.00033	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000193	0.000324	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000192	0.000324	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.000192	0.000323	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000192	0.000323	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SCT—polycystic ovary syndrome	0.000191	0.000321	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SCT—polycystic ovary syndrome	0.00019	0.00032	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.00019	0.000319	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NAMPT—polycystic ovary syndrome	0.00019	0.000319	CbGpPWpGaD
Cevimeline—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000189	0.000318	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000189	0.000317	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000188	0.000316	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP11A1—polycystic ovary syndrome	0.000187	0.000315	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	0.000187	0.000315	CbGpPWpGaD
Cevimeline—CHRM1—Circadian rythm related genes—IL6—polycystic ovary syndrome	0.000187	0.000314	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000182	0.000306	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.000182	0.000305	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000179	0.000301	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000178	0.0003	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000178	0.000298	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AKR1C3—polycystic ovary syndrome	0.000177	0.000298	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000177	0.000297	CbGpPWpGaD
Cevimeline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000177	0.000297	CbGpPWpGaD
Cevimeline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.000176	0.000296	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000175	0.000294	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP17A1—polycystic ovary syndrome	0.000174	0.000293	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000174	0.000293	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	0.000167	0.000281	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000166	0.000279	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000165	0.000278	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000163	0.000275	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000163	0.000274	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.000162	0.000272	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.000162	0.000272	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	0.000159	0.000268	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—INSR—polycystic ovary syndrome	0.000156	0.000263	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—INSR—polycystic ovary syndrome	0.000156	0.000262	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—TH—polycystic ovary syndrome	0.000151	0.000253	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000148	0.00025	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000148	0.000249	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—SLC2A4—polycystic ovary syndrome	0.000147	0.000247	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000146	0.000246	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000146	0.000245	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	0.000145	0.000244	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PGR—polycystic ovary syndrome	0.000145	0.000243	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PGR—polycystic ovary syndrome	0.000144	0.000242	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	0.000142	0.000239	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP19A1—polycystic ovary syndrome	0.000138	0.000232	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	0.000137	0.000231	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	0.000135	0.000228	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000135	0.000226	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000135	0.000226	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000134	0.000225	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000134	0.000225	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.00013	0.000218	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000129	0.000217	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	0.000128	0.000216	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000128	0.000216	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000128	0.000215	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	0.000127	0.000213	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000125	0.00021	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000125	0.00021	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000125	0.000209	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000124	0.000209	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—GNAS—polycystic ovary syndrome	0.000123	0.000207	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	0.000123	0.000206	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	0.000122	0.000206	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000118	0.000199	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	0.000118	0.000199	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000118	0.000198	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000118	0.000198	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PRL—polycystic ovary syndrome	0.000117	0.000197	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000117	0.000197	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NCOR1—polycystic ovary syndrome	0.000117	0.000197	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PRL—polycystic ovary syndrome	0.000117	0.000197	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	0.000113	0.000191	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000113	0.00019	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000113	0.00019	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	0.000112	0.000188	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000111	0.000187	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CYP1A1—polycystic ovary syndrome	0.000111	0.000187	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000111	0.000187	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	0.000109	0.000184	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	0.000106	0.000178	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	0.000104	0.000175	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	0.000104	0.000175	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MTHFR—polycystic ovary syndrome	0.000104	0.000174	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000103	0.000174	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000103	0.000173	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.84e-05	0.000165	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NCOR1—polycystic ovary syndrome	9.81e-05	0.000165	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NRG1—polycystic ovary syndrome	9.66e-05	0.000162	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NRG1—polycystic ovary syndrome	9.62e-05	0.000162	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	9.5e-05	0.00016	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	9.28e-05	0.000156	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—TH—polycystic ovary syndrome	9.02e-05	0.000152	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	8.99e-05	0.000151	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	8.77e-05	0.000147	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPARG—polycystic ovary syndrome	8.4e-05	0.000141	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—POMC—polycystic ovary syndrome	8.29e-05	0.000139	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	8.27e-05	0.000139	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IRS2—polycystic ovary syndrome	8.27e-05	0.000139	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	8.25e-05	0.000139	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IRS2—polycystic ovary syndrome	8.24e-05	0.000139	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—INS—polycystic ovary syndrome	8.24e-05	0.000139	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LEP—polycystic ovary syndrome	8.09e-05	0.000136	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LEP—polycystic ovary syndrome	8.07e-05	0.000136	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	8.01e-05	0.000135	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	7.72e-05	0.00013	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	7.42e-05	0.000125	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	7.36e-05	0.000124	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	7.33e-05	0.000123	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IRS1—polycystic ovary syndrome	7.22e-05	0.000121	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IRS1—polycystic ovary syndrome	7.2e-05	0.000121	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	7.01e-05	0.000118	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—POMC—polycystic ovary syndrome	6.95e-05	0.000117	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—POMC—polycystic ovary syndrome	6.93e-05	0.000117	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	6.92e-05	0.000116	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—INS—polycystic ovary syndrome	6.91e-05	0.000116	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—INS—polycystic ovary syndrome	6.89e-05	0.000116	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	6.81e-05	0.000115	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IGF1—polycystic ovary syndrome	6.69e-05	0.000112	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKT2—polycystic ovary syndrome	6.68e-05	0.000112	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF1—polycystic ovary syndrome	6.67e-05	0.000112	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKT2—polycystic ovary syndrome	6.66e-05	0.000112	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	6.65e-05	0.000112	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.35e-05	0.000107	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SERPINE1—polycystic ovary syndrome	6.33e-05	0.000106	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	6.2e-05	0.000104	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—TH—polycystic ovary syndrome	5.89e-05	9.91e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	5.73e-05	9.64e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	5.39e-05	9.06e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6—polycystic ovary syndrome	5.11e-05	8.6e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6—polycystic ovary syndrome	5.1e-05	8.57e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	5.02e-05	8.45e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	4.96e-05	8.33e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—INS—polycystic ovary syndrome	4.93e-05	8.28e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	4.81e-05	8.09e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	4.58e-05	7.71e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.37e-05	7.34e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VEGFA—polycystic ovary syndrome	4.35e-05	7.32e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	4.35e-05	7.31e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	4.05e-05	6.81e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	3.29e-05	5.52e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	3.24e-05	5.45e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—INS—polycystic ovary syndrome	3.22e-05	5.42e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6—polycystic ovary syndrome	3.02e-05	5.08e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6—polycystic ovary syndrome	3.01e-05	5.06e-05	CbGpPWpGaD
